Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects

American Journal of Health-System Pharmacy

Volumn 58, Issue 16, 2001, Pages 1512-1519

  Doan, T T ^a   Wang, Q ^a   Griffin, J S ^a   Lukasik, N L ^a   O'Dea, R F ^a   Pan, W J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Blood levels; Capsules; Dosage forms; Equivalency; Gastrointestinal drugs; Lansoprazole; Pharmacodynamics; Pharmacokinetics; Suspensions

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG FORMULATION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STOMACH PH; SUSPENSION;

EID: 0035881163     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.16.1512     Document Type: Article

References (27)

1. Acid suppression in duodenal ulcer: A meta-analysis to define optimal dosing with antisecretory drugs
2. Is there an optimal degree of acid suppression for healing of duodenal ulcer? A model of the relationship between ulcer healing and acid suppression
3. Appropriate acid suppression for the management of gastro-oesophageal reflux disease
4. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
5. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers
6. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion
7. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring
8. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion, and serum gastrin in healthy volunteers
9. Influence of lansoprazole 15 mg and omeprazole 20 mg and 40 mg on meal-stimulated gastric acid secretion
10. Comparison of the effects of lansoprazole and omeprazole on 24-hour gastric pH in normal male volunteers
11. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole
12. Pharmacokinetics and metabolism of omeprazole in man
13. Lansoprazole: An alternative method of administration of a capsule dosage formulation
14. Lansoprazole: Administration of the contents of a capsule dosage formulation through a nasogastric tube
15. Alternative methods of proton pump inhibitor administration
16. Lansoprazole effectively suppresses intragastric acidity when administered via gastrostomy as intact granules in orange juice
17. The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non-encapsulated granules
18. Simplified lansoprazole suspension (SLS): A proton pump inhibitor (PPI) in a liquid formulation that works
19. Simplified lansoprazole suspension - A liquid formulation of lansoprazole - Effectively suppresses intragastric acidity when administered through a gastrostomy
20. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole
21. Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate
22. Effects on 24 hour intragastric pH: A comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously
23. Metropolitan height and weight tables
24. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
25. Omeprazole and lansoprazole suspensions for nasogastric administration